Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

One of the hottest stocks in the S&P 500 is the biotech company Regeneron, which makes the drug Eylea. Yes, it's injected into your eye, and Medicare is spending hundreds of millions of dollars to keep our seniors seeing.